Description of the medicine: Pyridostigmine bromide (Pyridostigmini bromidum)
PYRIDOSTIGMINE BROMIDE (Pyridostigmini bromidum) 3- (Dimethylcarbamoyloxy) -1-methyl-pyridinium bromide.
Synonyms: Kalimin,, Mestinon, Kalymin, Mestinon.
Anticholinesterase agent (reversible action). By chemical structure and action is close to proserin. It is also a quaternary ammonium base and soderates the N-dimethylcarbamoyl group, which is linked by ether bond to the core.
Compared with proserin, it is somewhat less active and is used in higher doses, but it lasts longer.
Applied with myasthenia gravis, motor disorders after injuries, paralysis, in the recovery period after the transferred poliomyelitis, encephalitis, etc.
Assign adults to 0.06 g (1 dragee) 1 - 3 times a day, the children are reduced in accordance with the age.
Under the skin or intramuscularly administered to adults 0.4 to 1 ml of a 0.5% solution (2 to 5 mg). The dose is selected individually depending on the severity of the disease and tolerability.
Possible side effects and contraindications are the same as when using proserin.
Forms of release: tablets or dragees to 0.06 g; 0.5% solution in ampoules of 1 ml.
Storage: List A.